Charles R Peloquin

49PUBLICATIONS
129CO-AUTHORS
Clinical pharmacology and therapeuticsPharmacogenomicsMedical mycologyMolecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Jul 23, 2026
Consensus Guidance for Beta-Lactam Antibiotic Dose Individualization in Acutely Ill Patients: Endorsed by the American College of Clinical Pharmacy, European Society of Clinical Microbiology and Infectious Diseases, European Society of Clinical Microbiology and Infectious Diseases PK/PD of Anti-Infectives Study Group, Infectious Diseases Society of America, International Association of Therapeutic Drug Monitoring and Clinical Toxicology, Society of Critical Care Medicine, and the Society of Infectious Diseases Pharmacists.

|Mar 06, 2026
Pharmacokinetic and pharmacogenomic predictors of hepatotoxicity in the HIRIF trial for drug-susceptible tuberculosis.

Eunsol Yang, Pieter Van Brantegem, Charles A Peloquin

|Feb 23, 2026
Addition of Clofazimine Enhances the Activity of Standard Treatment Regimen in a Mouse Model of Tuberculous Meningitis.

Xueyi Chen, Carlos E Ruiz-Gonzalez, Yuderleys Masias-Leon

|Feb 10, 2026
Identifying optimal combination regimens for therapy of Mycobacterium tuberculosis with an algorithmic approach: prospective predictions and validations.

Arnold Louie, Michael Neely, Sarah Kim

|Feb 10, 2026
Beyond Rifampin: Evaluating Rifapentine and Rifabutin as Alternative Treatments for Tuberculous Meningitis.

Xueyi Chen, Carlos E Ruiz-Gonzalez, Yuderleys Masias-Leon

|Jan 16, 2026
Relapse and Emergent Resistance With Novel Short-Course Regimens for Multidrug-Resistant Tuberculosis, United States, 2022-2024.

Rina Liang, James C M Brust, Caitlin Reed

Pageof 9

Frequent Collaborators

15 joint publications

Mohammad H Alshaer

10 joint publications

Wael A Alghamdi

7 joint publications

Sarah Kim

6 joint publications

George L Drusano